Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Citadel Group Major Shareholding Notification 2020

Apr 30, 2020

10454_mrq_2020-04-30_7e67948a-829f-439c-b531-f96565796ec3.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 5217L

Citadel Group

30 April 2020

Ap 19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.         KEY INFORMATION

Name of person dealing (Note 1)

Citadel Group

Company dealt in

ALLERGAN PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

Common Stock ISIN IE00BY9D5467

Date of dealing

29 April, 2020

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security

dealt in (Note 3)

Long Short
Common Stock  ISIN  IE00BY9D5467 Number        (%) Number      (%)
(1) Relevant securities 3,107,791 (0.94%) 30 (0.00%)
(2) Derivatives (other than options) 3,465,201 (1.05%) 0 (0.00%)
(3) Options and agreements to purchase/sell 0 (0.00%) 0 (0.00%)
Total 6,572,992(2.00%) 30 (0.00%)

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Long Short
Number        (%) Number      (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap 20

1.         DEALINGS (Note 4)

(a)        Purchases and sales

Purchase/sale

Common Stock ISIN IE00BY9D5467
Number of securities Price per unit (Note 5)
Purchase 182 188.0828022  USD
Purchase 131 188.31236641  USD
Purchase 134 188.60238806  USD
Purchase 536 188.71529851  USD
Purchase 940 188.89653191  USD
Purchase 1,073 188.9933644  USD
Purchase 268 189.11343284  USD
Purchase 965 189.25291192  USD
Purchase 1 189.28  USD
Purchase 1,765 189.28130312  USD
Purchase 5,104 189.29  USD
Purchase 2,224 189.34142536  USD
Purchase 537 189.45560521  USD
Purchase 1,451 189.55639559  USD
Purchase 8 189.6  USD
Purchase 77 189.63  USD
Purchase 182 189.6332967  USD
Purchase 1,210 189.63804132  USD
Purchase 373 189.73621984  USD
Purchase 11 189.74  USD
Sale -200 186.9665  USD
Sale -10 187.05  USD
Sale -100 187.15  USD
Sale -100 187.4  USD
Sale -667 187.53745127  USD
Sale -1,517 187.74677653  USD
Sale -237 187.96156118  USD
Sale -289 188.06031142  USD
Sale -249 188.11289157  USD
Sale -110 188.32181818  USD
Sale -911 188.47514819  USD
Sale -297 188.48387205  USD
Sale -1,297 188.48466461  USD
Sale -277 188.61635379  USD
Sale -3,046 188.6709849  USD
Sale -3,418 188.68827092  USD
Sale -461 188.7924295  USD
Sale -100 188.81  USD
Sale -2,074 188.86618129  USD
Sale -3,077 188.99151771  USD
Sale -61 189.08377049  USD
Sale -269 189.21780669  USD
Sale -20,000 189.289966  USD
Sale -1,000 189.293  USD
Sale -200 189.36  USD
Sale -1,216 189.37370066  USD
Sale -100 189.48  USD
Sale -100 189.49  USD
Sale -300 189.51  USD
Sale -100 189.52  USD
Sale -100 189.56  USD
Sale -100 189.57  USD
Sale -39 189.62333333  USD
Sale -100 189.63  USD
Sale -195 189.63569231  USD
Sale -100 189.65  USD

(b)        Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

 ISIN
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c)        Options transactions in respect of existing relevant securities

(i)         Writing, selling, purchasing or varying

Product name, e.g. call option Writing, selling, purchasing,

varying etc.
Number of securities to which the option relates (Note 7) Exercise price Type,

e.g. American, European etc.
Expiry date Option money paid/ received per unit

(Note 5)

(ii)        Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit

(Note 5)

(d)        Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

      (if applicable) (Note 5)

Ap 21

2.         OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated
None

Is a Supplemental Form 8 attached? (Note 9)

NO

Date of disclosure: 30 April, 2020
Contact name: Katie Bonds
Telephone number: 020 7645 9700
If a connected EFM, name of offeree/offeror with which connected n/a
If a connected EFM, state nature of connection (Note 10) n/a

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ISEBBGDSCSXDGGG